Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

The early phase of an HIV epidemic in a population exposed previously to HCV in the Philippines.

Telan EF, Samonte GM, Abellanosa-Tac-An IP, Alesna ET, Leaño PS, Emphasis YE, Tsuneki A, Matsumoto K, Kageyama S.

J Med Virol. 2011 Jun;83(6):941-7. doi: 10.1002/jmv.22070.

PMID:
21503904
2.

Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines.

Kageyama S, Agdamag DM, Alesna ET, Abellanosa-Tac-An IP, Corpuz AC, Telan EF, Que ER, Leaño PS, Jereza LD, Emphasis YE, Prasetyo AA, Tanimoto T, Ichimura H.

J Med Virol. 2009 Jul;81(7):1157-62. doi: 10.1002/jmv.21516.

PMID:
19475613
3.

Rapid spread of hepatitis C virus among injecting-drug users in the Philippines: Implications for HIV epidemics.

Agdamag DM, Kageyama S, Alesna ET, Solante RM, Leaño PS, Heredia AM, Abellanosa-Tac-An IP, Vibal ET, Jereza LD, Ichimura H.

J Med Virol. 2005 Oct;77(2):221-6.

PMID:
16121359
4.

Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.

Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG; Cyprus IVDU Network, Kostrikis LG.

J Med Virol. 2010 Feb;82(2):263-70. doi: 10.1002/jmv.21690. Erratum in: J Med Virol. 2010 May;82(5):910-1.

PMID:
20029809
5.

Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.

Crofts N, Hopper JL, Milner R, Breschkin AM, Bowden DS, Locarnini SA.

Eur J Epidemiol. 1994 Dec;10(6):687-94.

PMID:
7672048
6.

Possible HIV transmission modes among at-risk groups at an early epidemic stage in the Philippines.

Telan EF, Samonte GM, Palaypayon N, Abellanosa-Tac-An IP, Leaño PS, Tsuneki A, Kageyama S.

J Med Virol. 2013 Dec;85(12):2057-64. doi: 10.1002/jmv.23701. Epub 2013 Aug 19.

PMID:
23959846
7.

Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.

Zhao R, Peng J, Tang L, Huang H, Liu M, Kong W, Pang B.

J Med Virol. 2013 Oct;85(10):1712-23. doi: 10.1002/jmv.23650. Epub 2013 Jul 19.

PMID:
23868809
8.

Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.

Devi KhS, Brajachand N, Singh HL, Singh YM.

J Commun Dis. 2005 Mar;37(1):73-7.

PMID:
16637404
9.

Coinfection with HIV and hepatitis C virus among injection drug users in southern China.

Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF.

Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S18-24.

PMID:
16265609
10.

Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.

Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV.

Int J STD AIDS. 2005 Nov;16(11):749-54.

PMID:
16303071
11.

High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China.

Zhang C, Yang R, Xia X, Qin S, Dai J, Zhang Z, Peng Z, Wei T, Liu H, Pu D, Luo J, Takebe Y, Ben K.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):191-6.

PMID:
11832691
12.

Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic.

Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, Prins M.

AIDS. 2009 Jul 31;23(12):F1-7. doi: 10.1097/QAD.0b013e32832e5631.

PMID:
19542864
13.

Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.

Vicknasingam B, Narayanan S, Navaratnam V.

Drug Alcohol Rev. 2009 Jul;28(4):447-54. doi: 10.1111/j.1465-3362.2009.00087.x.

PMID:
19594801
14.

Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.

Roy KM, Goldberg DJ, Hutchinson S, Cameron SO, Wilson K, MacDonald L.

J Med Virol. 2004 Sep;74(1):62-6.

PMID:
15258969
15.

Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.

Schleicher S, Schieffer M, Jürgens S, Wehner HD, Flehmig B.

Ig Sanita Pubbl. 2005 Sep-Oct;61(5):435-50.

PMID:
17214028
16.

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.

Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV.

J Viral Hepat. 2011 Apr;18(4):262-70. doi: 10.1111/j.1365-2893.2010.01297.x.

PMID:
20456636
17.

Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.

Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G.

J Med Virol. 2005 Jul;76(3):311-7.

PMID:
15902712
18.

Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.

Devi KhS, Singh NB, Singh HL, Singh YM.

J Indian Med Assoc. 2009 Mar;107(3):144, 146-7.

PMID:
19810379
19.
20.

Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.

Pereira GA, Stefani MM, Martelli CM, Turchi MD, Siqueira EM, Carneiro MA, Martins RM.

J Med Virol. 2006 Jun;78(6):719-23.

PMID:
16628586

Supplemental Content

Support Center